Transcriptional control of cytokine release from monocytes of the newborn: Effects of endogenous and exogenous interleukin-10 versus dexamethasone

Neonatology

Volumn 97, Issue 2, 2010, Pages 108-116

  Chusid, Lina A ^b   Pereira Argenziano, Lucy ^b   Miskolci, Veronika ^a,b   Vancurova, Ivana ^b,c   Davidson, Dennis ^a,b  

^a FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

^b SCHNEIDER CHILDREN'S HOSPITAL   (United States)

^c ST JOHN'S UNIVERSITY   (United States)

Author keywords

Cytokines; Dexamethasone; Interleukin 10; Monocyte; Transcription factors

Indexed keywords

CYTOKINE; DEXAMETHASONE; ENDOTOXIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 10 ANTIBODY; INTERLEUKIN 1BETA; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; STAT3 PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL ISOLATION; CELL STIMULATION; CONTROLLED STUDY; CULTURE MEDIUM; CYTOKINE RELEASE; DNA BINDING; DOSE RESPONSE; DRUG ACTIVITY; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; GEL MOBILITY SHIFT ASSAY; HUMAN; HUMAN CELL; HUMAN TISSUE; MONOCYTE; NEWBORN; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; TRANSCRIPTION REGULATION; UMBILICAL CORD BLOOD; WESTERN BLOTTING;

ANTIBODIES, MONOCLONAL; BLOTTING, WESTERN; CELLS, CULTURED; DEXAMETHASONE; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHORETIC MOBILITY SHIFT ASSAY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FETAL BLOOD; GLUCOCORTICOIDS; HUMANS; INFANT, NEWBORN; INTERLEUKIN-10; INTERLEUKIN-1BETA; INTERLEUKIN-8; LIPOPOLYSACCHARIDES; MACROPHAGES, ALVEOLAR; MONOCYTES; STAT3 TRANSCRIPTION FACTOR; TRANSCRIPTION FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 69149100523     PISSN: 16617800     EISSN: 16617819     Source Type: Journal    
DOI: 10.1159/000235807     Document Type: Article

References (35)

1. Gotsch F, Romero R, Kusanovic JP, Mazaki- Tovi S, Pineles BL, Erez O, Espinoza J, Hassan SS: The fetal inflammatory response syndrome. Clin Obstet Gynecol 2007; 50: 652-683.
2. Viscardi RM, Muhumuza CK, Rodriguez A, Fairchild KD, Sun CC, Gross GW, Campbell AB, Wilson PD, Hester L, Hasday JD: Inflammatory markers in intrauterine and fetal blood and cerebrospinal fluid compartments are associated with adverse pulmonary and neurologic outcomes in preterm infants. Pediatr Res 2004; 55: 1009-1017.
3. Merritt TA, Cochrane CG, Holcomb K, Bohl B, Hallman M, Strayer D, Edwards DK III, Gluck L: Elastase and 1 proteinase inhibitor activity in tracheal aspirates during respiratory distress syndrome. J Clin Invest 1983; 72: 656-666.
4. Jackson JC, Chi EY, Wilson CB, Truog WE, Teh EC, Hodson WA: Sequence of inflammatory cell migration into lung during recovery from hyaline membrane disease in premature newborn monkeys. Am Rev Respir Dis 1987; 135: 937-940.
5. Speer CP: Inflammation and bronchopulmonary dysplasia: a continuing story. Semin Fetal Neonatal Med 2006; 11: 354-362.
6. Hansen-Pupp I, Hallin AL, Hellstrom-Westas L, Cilio C, Berg AC, Stjernqvist K, Fellman V, Ley D: Inflammation at birth is associated with subnormal development in very preterm infants. Pediatr Res 2008; 64: 183-188.
7. Davidson D, Miskolci V, Clark DC, Dolmaian G, Vancurova I: Interleukin-10 production after pro-inflammatory stimulation of neutrophils and monocytic cells of the newborn: comparison to exogenous interleukin-10 and dexamethasone levels needed to inhibit chemokine release. Neonatology 2007; 92: 127-133.
8. Kramer BW, Jobe AH, Ikegami M: Monocyte function in preterm, term and adult sheep. Pediatr Res 2003; 54: 52-57.
9. Kramer BW, Ikegami M, Moss TJ, Nitsos I, Newnham JP, Jobe AH: Antenatal betamethasone changes cord blood monocyte responses to endotoxin in preterm lambs. Pediatr Res 2004; 55: 764-768.
10. Lewis DB, Wilson CB: Developmental immunology and role of host defenses in fetal and neonatal susceptibility too infection; in Remington J, Klein J, Baker C, Wilson C (eds): Infectious Diseases of the Fetus and Newborn Infant, ed 6. Philadelphia, Elsevier- Saunders, 2006, pp 149-159.
11. Xing L, Remick DG: Relative cytokine and cytokine inhibitor production by mononuclear cells and neutrophils. Shock 2003; 20: 10-16.
12. Committee on Fetus and Newborn: Postnatal corticosteroids to treat or prevent chronic lung disease in preterm infants. Pediatrics 2002; 109: 330-1308
13. Watterberg K: Anti-inflammatory therapy in the neonatal intensive care unit: present and future. Semin Fetal Neonatal Med 2006; 11: 378-384.
14. Schild PN, Charles BG: Determination of dexamethasone in plasma of premature neonates using high performance liquid chromatography. J Chromatogr B Biomed Appl 1994; 658: 189-192.
15. Lugo RA, Nahata MC, Menke JA, McClead RE Jr: Pharmacokinetics of dexamethasone in premature neonates. Eur J Clin Pharmacol 1996; 49: 477-483.
16. Kassel O, Herrlich P: Crosstalk between the glucocorticoid receptor and other transcription factors: molecular aspects. Mol Cell Endocrinol 2007; 275: 13-29.
17. Murray PJ: STAT3-mediated anti-inflammatory signalling. Biochem Soc Trans 2006; 34: 1028-1031.
18. Repnik U, Knezevic M, Jeras M: Simple and cost-effective isolation of monocytes from buffy coats. J Immunol Methods 2003; 278: 283-292.
19. Vancurova I, Miskolci V, Davidson D: NFB activation in tumor necrosis factor stimulated neutrophils is mediated by protein kinase C : correlation to nuclear IB . J Biol Chem 2001; 276: 19746-19752.
20. Castro-Alcaraz S, Miskolci V, Kalasapudi B, Davidson D, Vancurova I: NFB regulation in human neutrophils by nuclear IB : correlation to apoptosis. J Immunol 2002; 169: 3947-3953.
21. Berry SM, Romero R, Gomez R, Puder KS, Ghezzi F, Cotton DB, Bianchi DW: Premature parturition is characterized by in utero activation of the fetal immune system. Am J Obstet Gynecol 1995; 173: 1315-1320.
22. Murray PJ: Understanding and exploiting the endogenous interleukin-10/STAT3-mediated anti-inflammatory response. Curr Opin Pharmacol 2006; 6: 379-386.
23. Jones CA, Cayabyab RG, Kwong KY, Stotts C, Wong B, Hamdan H, Minoo P, deLemos RA: Undetectable interleukin (IL)-10 and persistent IL-8 expression early in hyaline membrane disease: a possible developmental basis for the predisposition to chronic lung inflammation in preterm newborns. Pediatr Res 1996; 39: 966-975.
24. McColm JR, Stenson BJ, Biermasz N, McIntosh N: Measurement of interleukin-10 in bronchoalveolar lavage from preterm ventilated infants. Arch Dis Child Fetal Neonatal Ed 2000; 82:F156-F159.
25. Beresford MW, Shaw NJ: Detectable IL-8 and IL-10 in bronchoalveolar lavage fluid from preterm infants ventilated for respiratory distress syndrome. Pediatr Res 2002; 52: 973-978.
26. Garingo A, Tesoriero L, Cayabyab R, Durand M, Blahnik M, Sardesai S, Ramanathan R, Jones C, Kwong K, Li C, Minoo P: Constitutive IL-10 expression by lung inflammatory cells and risk for bronchopulmonary dysplasia. Pediatr Res 2007; 61: 197-202.
27. Kwong KY, Jones CA, Cayabyab R, Lecart C, Khuu N, Rhandhawa I, Hanley JM, Ramanathan R, deLemos RA, Minoo P: The effects of IL-10 on proinflammatory cytokine expression (IL-1 and IL-8) in hyaline membrane disease (HMD). Clin Immunol Immunopathol 1998; 88: 105-113.
28. Lewis-Tuffin LJ, Cidlowski JA: The physiology of human glucocorticoid receptor beta (hGR) and glucocorticoid resistance. Ann NY Acad Sci 2006; 1069: 1-9.
29. Asadullah K, Sterry W, Volk HD: Interleukin-10 therapy-review of a new approach. Pharmacol Rev 2003; 55: 241-269.
30. Oberholzer A, Oberholzer C, Moldawer LL: Interleukin-10: A complex role in the pathogenesis of sepsis syndrome and its potential as an anti-inflammatory drug. Crit Care Med 2002; 30:S58-S63.
31. Parsons PE, Moss M, Vannice JL, Moore EE, Moore FA, Repine JE: Circulating IL-1ra and IL-10 levels are increased but do not predict the development of acute respiratory distress syndrome in at-risk patients. Am J Respir Crit Care Med 1997; 155: 1469-1473.
32. Miskolci V, Rollins J, Vu HY, Ghosh CC, Davidson D, Vancurova I: NFB is persistently activated in continuously stimulated human neutrophils. Mol Med 2007; 13: 134-142.
33. Shaulian E, Karin M: AP-1 as a regulator of cell life and death. Nat Cell Biol 2002; 4:E131-E136.
34. Fujioka S, Niu J, Schmidt C, Sclabas GM, Peng B, Uwagawa T, Li Z, Evans DB, Abbruzzese JL, Chiao PJ: NFB and AP-1 connection: mechanism of NFB-dependent regulation of AP-1 activity. Mol Cell Biol 2004; 24: 7806-7819.
35. Wang P, Wu P, Siegel MI, Egan RW, Billah MM: Interleukin (IL)-10 inhibits nuclear factor B (NFB) activation in human monocytes. IL-10 and IL-4 suppress cytokine synthesis by different mechanisms. J Biol Chem 1995; 270: 9558-9563.